Novaled wants to raise $200 million on the NASDAQ or the NYSE, and today the US Securities and Exchange Commission (SEC) released the company's filing, which reveales some interesting details. Novaled is selling its doping materials (produced by BASF), licenses OLED technology and also offers R&D services
First of all, here's a summary of the company's financial statements (all in Euro): in 2009 the company generated revenues of €6.4 million and a loss of €1.3 million, in 2010 revenues of €6.8 million and a loss of €2.3 million and in 2011 €17.4 in revenues and a profit of €1.2 million.
read more